title: Tamoxifen inhibits Ca2+ uptake by the cardiac sarcoplasmic reticulum.
abstract: Ca2+ transients in isolated cardiac ventricular myocytes and the amount of Ca2+ that could be released from the sarcoplasmic reticulum (SR) in these cells by caffeine were reduced in the presence of tamoxifen. To examine the effects of tamoxifen on the cardiac muscle SR directly, isolated SR vesicles and fluorimetry methods were used to measure the uptake of Ca2+ by the SR and the ATPase activity of the SR Ca2+ pump. SR Ca2+ uptake was inhibited by tamoxifen at concentrations greater than 2.4 microM. Half-maximal inhibition was seen at approximately 5 microM. Inhibition of uptake was not due to the development of a substantial tamoxifen-dependent leak of Ca2+ from the SR or to a direct inhibitory effect of tamoxifen on the ATPase activity of the SR Ca2+ pump. In addition to its effect on SR Ca2+ uptake, tamoxifen also reduced the rate at which stored Ca2+ could be released from the SR by the Ca2+ ionophore 4-bromo A23187. Our results are consistent with the hypothesis that tamoxifen inhibits an ion current that accompanies Ca2+ movement across the SR membrane. This possibility is also consistent with the known inhibitory action of tamoxifen on some types of Cl- and K+ channels.
authors.affiliation: Department of Physiology and Biophysics, University of Calgary, Alberta, Canada.
authors.forename: M E
authors.initials: ME
authors.lastname: Kargacin
authors.forename: Z
authors.initials: Z
authors.lastname: Ali
authors.forename: C A
authors.initials: CA
authors.lastname: Ward
authors.forename: N S
authors.initials: NS
authors.lastname: Pollock
authors.forename: G J
authors.initials: GJ
authors.lastname: Kargacin
mesh_terms: D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D000001:Calcimycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D004965:Estrogen Antagonists / Q000494:pharmacology*; D007476:Ionophores / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000648:ultrastructure*; D015221:Potassium Channels / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012519:Sarcoplasmic Reticulum / Q000187:drug effects* / Q000378:metabolism*; D013629:Tamoxifen / Q000494:pharmacology*; D019284:Thapsigargin / Q000494:pharmacology
chemical_list: D015220:Calcium Channels; D004965:Estrogen Antagonists; D007476:Ionophores; D015221:Potassium Channels; D013629:Tamoxifen; D000001:Calcimycin; D002110:Caffeine; D019284:Thapsigargin; C033170:4-bromo-A-23187; D000252:Calcium-Transporting ATPases; D002118:Calcium